STRS Ohio’s Terns Pharmaceuticals TERN Stock Holding History

STRS Ohio’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,700	Closed	-$880K	–	2321
2026 Q1	$880K	Sell	16,700 -5,100	-23%	-$209K	﹤0.01%	754
2025 Q4	$881K	Buy	+21,800	New	+$504K	﹤0.01%	745
2021 Q2	–	Sell	-2,100	Closed	-$46K	–	2424
2021 Q1	$46K	Buy	+2,100	New	+$46K	﹤0.01%	2042

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

STRS Ohio's TERN Position: Q2 2026 in Review

STRS Ohio sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 16,700 shares — an estimated $880K sold.

STRS Ohio first reported a position in TERN in Q1 2021 and held it in 3 quarters. The position peaked at $881K in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

STRS Ohio reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 16,700 Terns Pharmaceuticals shares in Q2 2026, an estimated $880K.
STRS Ohio first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 3 quarters.
STRS Ohio's Terns Pharmaceuticals position peaked at $881K in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.